Arthrex® AR-502-4RRecalls & reported problems
Arthrex, Inc. · IBAL PATLOFEM IMPL,SZ 4,RT · Class 2 · Implant
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00888867034679), received between Sep 25, 2024 and Sep 25, 2024 — classified as 1 injury.
The most frequently reported specific device problem is “Break” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Reports received per month
Most reported problems
Device problems
- Break1
- Device Dislodged or Dislocated1
Patient problems
- Failure of Implant1
- Implant Pain1
- Joint effusion1
- Loss of Range of Motion1
- Swelling/ Edema1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
InjurySep 25, 2024Break; Device Dislodged or Dislocated; Break; Device Dislodged or Dislocated
ON 08/26/2024, IT WAS REPORTED BY A PATIENT VIA PHONE THAT THE PATIENT HAD SURGERY ON (B)(6) 2018 FOR A RIGHT KNEE PATELLOFEMORAL JOINT REPLACEMENT. AFTER THE SURGERY, THE PATIENT EXPERIENCED PAIN WHEN LYING DOWN AND LATER ON EXPERIENCED SHARP PAIN IN THE BACK OF THE LEG WHEN GOING UP THE STAIRS WITH THE PATIENT'S LEG GIVING OUT. AN X-RAY WAS PERFORMED AFTERWARD AND SHOWED THAT THE UNKNOWN ARTHREX PART NUMBER THAT WAS IMPLANTED ON (B)(6) 2018 HAD COME APART/BROKEN. PER THE PATIENT, THE SURGEON STATED THIS WAS NOT NORMAL AND PERFORMED AN ARTHROPLASTY TOTAL REVISION SURGERY ON THE RIGHT KNEE ON (B)(6) 2024 TO REMOVE THE BROKEN PART AND PUT A NEW PART IN. BOTH SURGERIES WERE PERFORMED BY THE SAME SURGEON AT DIFFERENT FACILITIES. ADDITIONAL INFORMATION RECEIVED ON 9/5/2024: THE MEDICAL RECORDS INDICATE THAT THE PATIENT DID WELL FOLLOWING HIS 2018 SURGERY UNTIL HE FIRST EXPERIENCED RIGHT POSTERIOR KNEE PAIN ABOUT A YEAR AGO. THE PATIENT REPORTED THAT THERE WAS NO PRECEDING INJURY OR TRAUMA. THE PATIENT BELIEVES THE PAIN BEGAN SHORTLY AFTER RECEIVING STEM CELL INJECTIONS ON THE RIGHT FOOT. THE PATIENT'S SYMPTOMS WORSENED ON (B)(6) 2024 THE PATIENT EXPERIENCED SHARP PAIN IN THE BACK OF TH
Patient problems: Failure of Implant; Implant Pain; Joint effusion; Loss of Range of Motion; Swelling/ Edema
MAUDE report 20299961 ↗
Other PROSTHESIS, KNEE, PATELLO/FEMORAL, SEMI-CONSTRAINED, CEMENTED, METAL/POLYMER devices
- Scorpio 73-3910Howmedica Osteonics Corp. · PROSTHESIS, KNEE, PATELLO/FEMORAL, SEMI-CONSTRAINED, CEMENTED, METAL/POLYMER2 recalls4 reports
- Scorpio 73-3508Howmedica Osteonics Corp. · PROSTHESIS, KNEE, PATELLO/FEMORAL, SEMI-CONSTRAINED, CEMENTED, METAL/POLYMER2 recalls3 reports
- Arthrex® AR-503-TTTCArthrex, Inc. · PROSTHESIS, KNEE, PATELLO/FEMORAL, SEMI-CONSTRAINED, CEMENTED, METAL/POLYMER1 recall15 reports
- Arthrex® AR-503-TTTFArthrex, Inc. · PROSTHESIS, KNEE, PATELLO/FEMORAL, SEMI-CONSTRAINED, CEMENTED, METAL/POLYMER1 recall7 reports
- Scorpio 73-3308Howmedica Osteonics Corp. · PROSTHESIS, KNEE, PATELLO/FEMORAL, SEMI-CONSTRAINED, CEMENTED, METAL/POLYMER1 recall0 reports
- Arthrex® AR-504-PSC9Arthrex, Inc. · PROSTHESIS, KNEE, PATELLO/FEMORAL, SEMI-CONSTRAINED, CEMENTED, METAL/POLYMER11 reports
- RESTORIS 160405Mako Surgical Corp. · PROSTHESIS, KNEE, PATELLO/FEMORAL, SEMI-CONSTRAINED, CEMENTED, METAL/POLYMER7 reports
- Arthrex® AR-504-PSD0Arthrex, Inc. · PROSTHESIS, KNEE, PATELLO/FEMORAL, SEMI-CONSTRAINED, CEMENTED, METAL/POLYMER7 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page